Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 1997

View Archived Issues

Annual Report: Peptech

MedImmune reports product sales increase 250% for Q4 1996

Cortex fiscal 1997 second-quarter and six-month results

Lidak announces first-quarter fiscal 1997 financial results

AEterna's 1996 financial results

Sugen continues to focus on TK inhibitors

Gliatech prepares H3 agonists

Antiproliferative agents from Pfizer

U.S. researchers prepare chloroquine analogues

Agents for BPH disclosed by Merck & Co.

SKB prepares cytokine inhibitors

University of California researchers report pseudopterosin derivatives

Antiarrhythmic agents from Merck & Co.

GRC-active agents from CoCensys modulate brain excitability

Another launch for SKB vaccine

Antiacne treatment available in the U.K.

First launch for lipid-lowering statin

Astra anesthetic/analgesic introduced in the U.K.

U.K. launch for P&U glaucoma Rx

New paclitaxel combination demonstrates enhanced efficacy

Efficacy of leukotriene antagonist in asthma

Role of bFGF in gastric ulcer healing

New ACAT inhibitor associated with diarrhea

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...